{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:41:17Z","timestamp":1791549677521,"version":"4.3.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012172","name":"Breast Cancer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012172","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ontario Graduate Scholarships"},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["#391682"],"award-info":[{"award-number":["#391682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["#391682"],"award-info":[{"award-number":["#391682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["#391682"],"award-info":[{"award-number":["#391682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["#391682"],"award-info":[{"award-number":["#391682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["#391682"],"award-info":[{"award-number":["#391682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["#391682"],"award-info":[{"award-number":["#391682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["#391682"],"award-info":[{"award-number":["#391682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["#391682"],"award-info":[{"award-number":["#391682"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canadian Foundation for Innovation J. Evans Leaders Fund grant","award":["#43481"],"award-info":[{"award-number":["#43481"]}]},{"name":"Canadian Foundation for Innovation J. Evans Leaders Fund grant","award":["#43481"],"award-info":[{"award-number":["#43481"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-025-02080-z","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:52:48Z","timestamp":1751953968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy"],"prefix":"10.1186","volume":"27","author":[{"given":"Noor","family":"Rizvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseos J.","family":"Mucaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Salmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Trebinjac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Paszat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Nofech-Mozes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Rakovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Dumeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2080_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer Nat Rev Dis Primer. 2019;5:1\u201331.","journal-title":"Breast cancer Nat Rev Dis Primer"},{"key":"2080_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.breast.2010.05.014","volume":"19","author":"R S\u00f8rum","year":"2010","unstructured":"S\u00f8rum R, Hofvind S, Skaane P, Haldorsen T. Trends in incidence of ductal carcinoma in situ: The effect of a population-based screening programme. The Breast. 2010;19:499\u2013505.","journal-title":"The Breast"},{"key":"2080_CR3","first-page":"905","volume":"24","author":"RE Gangnon","year":"2015","unstructured":"Gangnon RE, Sprague BL, Stout NK, Alagoz O, Weedon-Fekj\u00e6r H, Holford TR, et al. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2015;24:905\u201312.","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"2080_CR4","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2024.5534","volume":"331","author":"UPST Force","year":"2024","unstructured":"Force UPST, Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, et al. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2024;331:1918\u201330.","journal-title":"JAMA"},{"key":"2080_CR5","unstructured":"Tomlinson-Hansen S, Khan M, Cassaro S. Breast Ductal Carcinoma in Situ. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567766\/.\u00a0Cited 2023 Nov 16."},{"key":"2080_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11684-018-0656-6","volume":"12","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med. 2018;12:361\u201373.","journal-title":"Front Med"},{"key":"2080_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.breast.2022.01.001","volume":"61","author":"AJ Maxwell","year":"2022","unstructured":"Maxwell AJ, Hilton B, Clements K, Dodwell D, Dulson-Cox J, Kearins O, et al. Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study. Breast Edinb Scotl. 2022;61:145\u201355.","journal-title":"Breast Edinb Scotl"},{"key":"2080_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10549-018-4693-2","volume":"169","author":"E Rakovitch","year":"2018","unstructured":"Rakovitch E, Gray R, Baehner FL, Sutradhar R, Crager M, Gu S, et al. Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies. Breast Cancer Res Treat. 2018;169:359\u201369.","journal-title":"Breast Cancer Res Treat"},{"key":"2080_CR9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1158\/0008-5472.CAN-16-1553","volume":"77","author":"N Andor","year":"2017","unstructured":"Andor N, Maley CC, Ji HP. Genomic instability in cancer: Teetering on the limit of tolerance. Cancer Res. 2017;77:2179\u201385.","journal-title":"Cancer Res"},{"key":"2080_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1158\/1541-7786.MCR-20-0949","volume":"19","author":"A Trinh","year":"2021","unstructured":"Trinh A, Gil Del Alcazar CR, Shukla SA, Chin K, Chang YH, Thibault G, et al. Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System. Mol Cancer Res. 2021;19:623\u201335.","journal-title":"Mol Cancer Res"},{"key":"2080_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-019-05401-x","volume":"178","author":"C-Y Lin","year":"2019","unstructured":"Lin C-Y, Vennam S, Purington N, Lin E, Varma S, Han S, et al. Genomic landscape of ductal carcinoma in situ and association with progression. Breast Cancer Res Treat. 2019;178:307\u201316.","journal-title":"Breast Cancer Res Treat"},{"key":"2080_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/path.3990","volume":"227","author":"L Hernandez","year":"2012","unstructured":"Hernandez L, Wilkerson PM, Lambros MB, Campion-Flora A, Rodrigues DN, Gauthier A, et al. Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection. J Pathol. 2012;227:42\u201352.","journal-title":"J Pathol"},{"key":"2080_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-01959-9","volume":"4","author":"S Nagasawa","year":"2021","unstructured":"Nagasawa S, Kuze Y, Maeda I, Kojima Y, Motoyoshi A, Onishi T, et al. Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast. Commun Biol. 2021;4:1\u201313.","journal-title":"Commun Biol"},{"key":"2080_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-021-00365-y","volume":"8","author":"D Nachmanson","year":"2022","unstructured":"Nachmanson D, Officer A, Mori H, Gordon J, Evans MF, Steward J, et al. The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ. Npj Breast Cancer. 2022;8:1\u201313.","journal-title":"Npj Breast Cancer"},{"key":"2080_CR15","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-15-0506","volume":"75","author":"MC Abba","year":"2015","unstructured":"Abba MC, Gong T, Lu Y, Lee J, Zhong Y, Lacunza E, et al. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ. Cancer Res. 2015;75:3980\u201390.","journal-title":"Cancer Res"},{"key":"2080_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10549-024-07270-5","volume":"205","author":"HG Kaplan","year":"2024","unstructured":"Kaplan HG, Dowdell AK, Berry AB, Shimol RB, Robinson FL, Carney CA, et al. Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res Treat. 2024;205:451\u201364.","journal-title":"Breast Cancer Res Treat"},{"key":"2080_CR17","doi-asserted-by":"crossref","unstructured":"Kader T, Hill P, Zethoven M, Goode DL, Elder K, Thio N, et al. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma. J Pathol. 2019;248:326\u201338.","DOI":"10.1002\/path.5262"},{"key":"2080_CR18","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.18632\/oncotarget.3162","volume":"6","author":"SY Kim","year":"2015","unstructured":"Kim SY, Jung S-H, Kim MS, Baek I-P, Lee SH, Kim T-M, et al. Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer. Oncotarget. 2015;6:7597\u2013607.","journal-title":"Oncotarget"},{"key":"2080_CR19","doi-asserted-by":"crossref","unstructured":"Pareja F, Brown DN, Lee JY, Da Cruz Paula A, Selenica P, Bi R, et al. Whole-Exome Sequencing Analysis of the Progression from Non\u2013Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma. Clin Cancer Res. 2020;26:3682\u201393.","DOI":"10.1158\/1078-0432.CCR-19-2563"},{"key":"2080_CR20","doi-asserted-by":"crossref","unstructured":"Strand SH, Rivero-Guti\u00e9rrez B, Houlahan KE, Seoane JA, King LM, Risom T, et al. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 2022;40:1521\u201336.e7.","DOI":"10.1016\/j.ccell.2022.10.021"},{"key":"2080_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/1479-7364-4-6-406","volume":"4","author":"DN Cooper","year":"2010","unstructured":"Cooper DN, Mort M, Stenson PD, Ball EV, Chuzhanova NA. Methylation-mediated deamination of 5-methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides. Hum Genomics. 2010;4:406\u201310.","journal-title":"Hum Genomics"},{"key":"2080_CR22","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","volume":"47","author":"LB Alexandrov","year":"2015","unstructured":"Alexandrov LB, Jones PH, Wedge DC, Sale JE, Campbell PJ, Nik-Zainal S, et al. Clock-like mutational processes in human somatic cells. Nat Genet. 2015;47:1402\u20137.","journal-title":"Nat Genet"},{"key":"2080_CR23","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1093\/nar\/gkad519","volume":"51","author":"TA Steiert","year":"2023","unstructured":"Steiert TA, Parra G, Gut M, Arnold N, Trotta J-R, Tonda R, et al. A critical spotlight on the paradigms of FFPE-DNA sequencing. Nucleic Acids Res. 2023;51:7143\u201362.","journal-title":"Nucleic Acids Res"},{"key":"2080_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321.","journal-title":"Nature"},{"key":"2080_CR25","doi-asserted-by":"crossref","unstructured":"Guo Q, Lakatos E, Bakir IA, Curtius K, Graham TA, Mustonen V. The mutational signatures of formalin fixation on the human genome. bioRxiv; 2021. p. 2021.03.11.434918. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2021.03.11.434918v1.\u00a0Cited 2024 Dec 6.","DOI":"10.1101\/2021.03.11.434918"},{"key":"2080_CR26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena I, Raine KM, Gerstung M, Dawson KJ, Haase K, Loo PV, et al. Universal Patterns of Selection in Cancer and Somatic Tissues. Cell. 2017;171:1029-1041.e21.","journal-title":"Cell"},{"key":"2080_CR27","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1038\/onc.2008.245","volume":"27","author":"T Yuan","year":"2008","unstructured":"Yuan T, Cantley L. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008;27:5497\u2013510.","journal-title":"Oncogene"},{"key":"2080_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nrc1753","volume":"5","author":"AG Bader","year":"2005","unstructured":"Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer. 2005;5:921\u20139.","journal-title":"Nat Rev Cancer"},{"key":"2080_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1006\/geno.1999.5967","volume":"61","author":"XH Yang","year":"1999","unstructured":"Yang XH, Huang S. PFM1 (PRDM4), a new member of the PR-domain family, maps to a tumor suppressor locus on human chromosome 12q23-q24.1. Genomics. 1999;61:319\u201325.","journal-title":"Genomics."},{"key":"2080_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12079-009-0072-4","volume":"3","author":"SA Arnold","year":"2009","unstructured":"Arnold SA, Brekken RA. SPARC: a matricellular regulator of tumorigenesis. J Cell Commun Signal. 2009;3:255\u201373.","journal-title":"J Cell Commun Signal"},{"key":"2080_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/onc.2008.381","volume":"28","author":"A Vecchione","year":"2009","unstructured":"Vecchione A, Fassan M, Anesti V, Morrione A, Goldoni S, Baldassarre G, et al. MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer. Oncogene. 2009;28:257\u201369.","journal-title":"Oncogene."},{"key":"2080_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10549-006-9377-7","volume":"103","author":"G Heller","year":"2007","unstructured":"Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger E-M, et al. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat. 2007;103:283\u201391.","journal-title":"Breast Cancer Res Treat"},{"key":"2080_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/bcr294","volume":"3","author":"K Kittiniyom","year":"2001","unstructured":"Kittiniyom K, Gorse KM, Dalbegue F, Lichy JH, Taubenberger JK, Newsham IF. Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression. Breast Cancer Res. 2001;3:192\u20138.","journal-title":"Breast Cancer Res."},{"key":"2080_CR34","first-page":"355","volume":"7","author":"E Schuuring","year":"1992","unstructured":"Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ. Identification and cloning of two overexpressed genes, U21B31\/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. 1992;7:355\u201361.","journal-title":"Oncogene"},{"key":"2080_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1023\/A:1023033708204","volume":"78","author":"CJ Ormandy","year":"2003","unstructured":"Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL. Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer. Breast Cancer Res Treat. 2003;78:323\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"2080_CR36","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1101\/gr.231696.117","volume":"28","author":"AA Houle","year":"2018","unstructured":"Houle AA, Gibling H, Lamaze FC, Edgington HA, Soave D, Fave M-J, et al. Aberrant PRDM9 expression impacts the pan-cancer genomic landscape. Genome Res. 2018;28:1611\u201320.","journal-title":"Genome Res"},{"key":"2080_CR37","unstructured":"Kader T, Zethoven M, Mahale S, Saunders H, Tjoeka L, Lehmann R, et al. Predictive biomarkers of breast ductal carcinoma in situ may underestimate the risk of recurrence due to de novo ipsilateral breast carcinoma development. bioRxiv; 2024. p. 2024.05.19.594731. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2024.05.19.594731v1.Cited 2025 Jan 3."},{"key":"2080_CR38","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/modpathol.2013.197","volume":"27","author":"DC Ang","year":"2014","unstructured":"Ang DC, Warrick AL, Shilling A, Beadling C, Corless CL, Troxell ML. Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions. Mod Pathol. 2014;27:740\u201350.","journal-title":"Mod Pathol"},{"key":"2080_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026252","volume":"7","author":"L Silwal-Pandit","year":"2017","unstructured":"Silwal-Pandit L, Langer\u00f8d A, B\u00f8rresen-Dale A-L. TP53 Mutations in Breast and Ovarian Cancer. Cold Spring Harb Perspect Med. 2017;7: a026252.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2080_CR40","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/modpathol.2017.21","volume":"30","author":"J-MB Pang","year":"2017","unstructured":"Pang J-MB, Savas P, Fellowes AP, Mir Arnau G, Kader T, Vedururu R, et al. Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer. Mod Pathol. 2017;30:952\u201363.","journal-title":"Mod Pathol."},{"key":"2080_CR41","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.celrep.2016.06.051","volume":"16","author":"R Lesurf","year":"2016","unstructured":"Lesurf R, Aure MR, M\u00f8rk HH, Vitelli V, Lundgren S, B\u00f8rresen-Dale A-L, et al. Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer. Cell Rep. 2016;16:1166\u201379.","journal-title":"Cell Rep"},{"key":"2080_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41523-020-0167-x","volume":"6","author":"H Bergholtz","year":"2020","unstructured":"Bergholtz H, Lien TG, Swanson DM, Frigessi A, Daidone MG, Tost J, et al. Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions. NPJ Breast Cancer. 2020;6:26.","journal-title":"NPJ Breast Cancer"},{"key":"2080_CR43","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2353\/ajpath.2009.090115","volume":"175","author":"LA Emery","year":"2009","unstructured":"Emery LA, Tripathi A, King C, Kavanah M, Mendez J, Stone MD, et al. Early Dysregulation of Cell Adhesion and Extracellular Matrix Pathways in Breast Cancer Progression. Am J Pathol. 2009;175:1292\u2013302.","journal-title":"Am J Pathol"},{"key":"2080_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ceb.2013.06.010","volume":"25","author":"MA Glukhova","year":"2013","unstructured":"Glukhova MA, Streuli CH. How integrins control breast biology. Curr Opin Cell Biol. 2013;25:633\u201341.","journal-title":"Curr Opin Cell Biol"},{"key":"2080_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001199","volume":"9","author":"CA Maxwell","year":"2011","unstructured":"Maxwell CA, Ben\u00edtez J, G\u00f3mez-Bald\u00f3 L, Osorio A, Bonifaci N, Fern\u00e1ndez-Ramires R, et al. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol. 2011;9: e1001199.","journal-title":"PLoS Biol"},{"key":"2080_CR46","doi-asserted-by":"publisher","unstructured":"Qin X, Strand SH, Lee MR, Saraswathibhatla A, van IJzendoorn DGP, Zhu C, et al. Single Cell Expression Analysis of Ductal Carcinoma in Situ Identifies Complex Genotypic-Phenotypic Relationships Altering Epithelial Composition. Cancer Res. 2025. Available from: https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-3023.\u00a0Cited 2025 Apr 21.","DOI":"10.1158\/0008-5472.CAN-24-3023"},{"key":"2080_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbm.2023.100037","volume":"2","author":"Y Deng","year":"2024","unstructured":"Deng Y, Chen G, Xiao J, Deng H. Role and potential therapeutic strategies of matrix mechanics for optimizing tumor radiotherapy. Mechanobiol Med. 2024;2: 100037.","journal-title":"Mechanobiol Med"},{"key":"2080_CR48","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer Discov. 2024;14:1375\u201388.","journal-title":"Cancer Discov"},{"key":"2080_CR49","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41598-023-50473-x","volume":"14","author":"C Frascogna","year":"2024","unstructured":"Frascogna C, Mottareale R, La Verde G, Arrichiello C, Muto P, Netti PA, et al. Role of the mechanical microenvironment on CD-44 expression of breast adenocarcinoma in response to radiotherapy. Sci Rep. 2024;14:391.","journal-title":"Sci Rep"},{"key":"2080_CR50","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10549-013-2455-8","volume":"138","author":"E Rakovitch","year":"2013","unstructured":"Rakovitch E, Nofech-Mozes S, Narod SA, Hanna W, Thiruchelvam D, Saskin R, et al. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Res Treat. 2013;138:581\u201390.","journal-title":"Breast Cancer Res Treat"},{"key":"2080_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","volume":"152","author":"E Rakovitch","year":"2015","unstructured":"Rakovitch E, Nofech-Mozes S, Hanna W, Baehner FL, Saskin R, Butler SM, et al. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res Treat. 2015;152:389\u201398.","journal-title":"Breast Cancer Res Treat"},{"key":"2080_CR52","doi-asserted-by":"publisher","first-page":"djw256","DOI":"10.1093\/jnci\/djw256","volume":"109","author":"E Rakovitch","year":"2017","unstructured":"Rakovitch E, Nofech-Mozes S, Hanna W, Sutradhar R, Baehner FL, Miller DP, et al. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ. J Natl Cancer Inst. 2017;109:djw256.","journal-title":"J Natl Cancer Inst."},{"key":"2080_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.clbc.2018.07.018","volume":"19","author":"L Paszat","year":"2019","unstructured":"Paszat L, Sutradhar R, Zhou L, Nofech-Mozes S, Rakovitch E. Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS. Clin Breast Cancer. 2019;19:35\u201346.","journal-title":"Clin Breast Cancer"},{"key":"2080_CR54","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s40064-015-1032-5","volume":"4","author":"J Klein","year":"2015","unstructured":"Klein J, Kong I, Paszat L, Nofech-Mozes S, Hanna W, Thiruchelvam D, et al. Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysis. Springerplus. 2015;4:335.","journal-title":"Springerplus"},{"key":"2080_CR55","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ijrobp.2014.07.026","volume":"90","author":"N Lalani","year":"2014","unstructured":"Lalani N, Paszat L, Sutradhar R, Thiruchelvam D, Nofech-Mozes S, Hanna W, et al. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2014;90:1017\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2080_CR56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10549-021-06187-7","volume":"188","author":"E Rakovitch","year":"2021","unstructured":"Rakovitch E, Parpia S, Koch A, Grimard L, Soliman H, Stevens C, et al. DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low\/intermediate-risk DCIS. Breast Cancer Res Treat. 2021;188:133\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"2080_CR57","unstructured":"Krueger F. FelixKrueger\/TrimGalore. 2025. Available from: https:\/\/github.com\/FelixKrueger\/TrimGalore.\u00a0Cited 2025 Jun 2."},{"key":"2080_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinforma Oxf Engl. 2013;29:15\u201321.","journal-title":"Bioinforma Oxf Engl"},{"key":"2080_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47: e47.","journal-title":"Nucleic Acids Res"},{"key":"2080_CR60","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106.","journal-title":"Genome Biol"},{"key":"2080_CR61","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","volume":"32","author":"DMA Gendoo","year":"2016","unstructured":"Gendoo DMA, Ratanasirigulchai N, Schr\u00f6der MS, Par\u00e9 L, Parker JS, Prat A, et al. Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer. Bioinforma Oxf Engl. 2016;32:1097\u20139.","journal-title":"Bioinforma Oxf Engl"},{"key":"2080_CR62","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, et al. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. J Clin Oncol. 2009;27:1160\u20137.","journal-title":"J Clin Oncol"},{"key":"2080_CR63","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinforma Oxf Engl. 2014;30:2114\u201320.","journal-title":"Bioinforma Oxf Engl"},{"key":"2080_CR64","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv.org. 2013. Available from:\u00a0https:\/\/arxiv.org\/abs\/1303.3997v2.\u00a0Cited 2024 Apr 8."},{"key":"2080_CR65","doi-asserted-by":"crossref","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. GigaScience. 2021;10:giab008.","DOI":"10.1093\/gigascience\/giab008"},{"key":"2080_CR66","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41467-019-09027-x","volume":"10","author":"SME Sahraeian","year":"2019","unstructured":"Sahraeian SME, Liu R, Lau B, Podesta K, Mohiyuddin M, Lam HYK. Deep convolutional neural networks for accurate somatic mutation detection. Nat Commun. 2019;10:1041.","journal-title":"Nat Commun"},{"key":"2080_CR67","unstructured":"Benjamin D, Sato T, Cibulskis K, Getz G, Stewart C, Lichtenstein L. Calling Somatic SNVs and Indels with Mutect2. 201. Available from:\u00a0http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/861054. Cited 2024 Apr 8."},{"key":"2080_CR68","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13059-016-1029-6","volume":"17","author":"Y Fan","year":"2016","unstructured":"Fan Y, Xi L, Hughes DST, Zhang J, Zhang J, Futreal PA, et al. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data. Genome Biol. 2016;17:178.","journal-title":"Genome Biol"},{"key":"2080_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw227","volume":"44","author":"Z Lai","year":"2016","unstructured":"Lai Z, Markovets A, Ahdesmaki M, Chapman B, Hofmann O, McEwen R, et al. VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res. 2016;44: e108.","journal-title":"Nucleic Acids Res"},{"key":"2080_CR70","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568\u201376.","journal-title":"Genome Res"},{"key":"2080_CR71","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim S, Scheffler K, Halpern AL, Bekritsky MA, Noh E, K\u00e4llberg M, et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods. 2018;15:591\u20134.","journal-title":"Nat Methods"},{"key":"2080_CR72","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","volume":"28","author":"DE Larson","year":"2012","unstructured":"Larson DE, Harris CC, Chen K, Koboldt DC, Abbott TE, Dooling DJ, et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics. 2012;28:311.","journal-title":"Bioinformatics"},{"key":"2080_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13059-021-02592-9","volume":"23","author":"SME Sahraeian","year":"2022","unstructured":"Sahraeian SME, Fang LT, Karagiannis K, Moos M, Smith S, Santana-Quintero L, et al. Achieving robust somatic mutation detection with deep learning models derived from reference data sets of a cancer sample. Genome Biol. 2022;23:12.","journal-title":"Genome Biol"},{"key":"2080_CR74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12864-022-08365-3","volume":"23","author":"YA Barbitoff","year":"2022","unstructured":"Barbitoff YA, Abasov R, Tvorogova VE, Glotov AS, Predeus AV. Systematic benchmark of state-of-the-art variant calling pipelines identifies major factors affecting accuracy of coding sequence variant discovery. BMC Genomics. 2022;23:155.","journal-title":"BMC Genomics"},{"key":"2080_CR75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12920-020-00746-5","volume":"13","author":"L de Schaetzen van Brienen","year":"2020","unstructured":"de Schaetzen van Brienen L, Larmuseau M, Van der Eecken K, De Ryck F, Robbe P, Schuh A, et al. Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples. BMC Med Genomics. 2020;13:94.","journal-title":"BMC Med Genomics."},{"key":"2080_CR76","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41576-023-00590-0","volume":"24","author":"ND Olson","year":"2023","unstructured":"Olson ND, Wagner J, Dwarshuis N, Miga KH, Sedlazeck FJ, Salit M, et al. Variant calling and benchmarking in an era of complete human genome sequences. Nat Rev Genet. 2023;24:464\u201383.","journal-title":"Nat Rev Genet"},{"key":"2080_CR77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122.","journal-title":"Genome Biol"},{"key":"2080_CR78","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12920-014-0064-y","volume":"7","author":"C Shyr","year":"2014","unstructured":"Shyr C, Tarailo-Graovac M, Gottlieb M, Lee JJ, van Karnebeek C, Wasserman WW. FLAGS, frequently mutated genes in public exomes. BMC Med Genomics. 2014;7:64.","journal-title":"BMC Med Genomics"},{"key":"2080_CR79","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/s41467-023-39313-8","volume":"14","author":"F Alfieri","year":"2023","unstructured":"Alfieri F, Caravagna G, Schaefer MH. Cancer genomes tolerate deleterious coding mutations through somatic copy number amplifications of wild-type regions. Nat Commun. 2023;14:3594.","journal-title":"Nat Commun"},{"key":"2080_CR80","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin D-C, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747\u201356.","journal-title":"Genome Res"},{"key":"2080_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-018-0539-0","volume":"10","author":"F Blokzijl","year":"2018","unstructured":"Blokzijl F, Janssen R, van Boxtel R, Cuppen E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. 2018;10:33.","journal-title":"Genome Med"},{"key":"2080_CR82","doi-asserted-by":"crossref","unstructured":"Raivo Kolde. pheatmap: Pretty Heatmaps. 2010. p. 1.0.12. Available from:\u00a0https:\/\/CRAN.R-project.org\/package=pheatmap. Cited 2025 May 20.","DOI":"10.32614\/CRAN.package.pheatmap"},{"key":"2080_CR83","unstructured":"Martincorena I. im3sanger\/dndscv. 2025. Available from:\u00a0https:\/\/github.com\/im3sanger\/dndscv. Cited 2025 May 20."},{"key":"2080_CR84","unstructured":"Mutation data transcript annotation. Available from:\u00a0https:\/\/docs.cbioportal.org\/mutation-data-transcript-annotation\/. Cited 2025 May 20."},{"key":"2080_CR85","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1158\/2159-8290.CD-17-0321","volume":"8","author":"MT Chang","year":"2018","unstructured":"Chang MT, Bhattarai TS, Schram AM, Bielski CM, Donoghue MTA, Jonsson P, et al. Accelerating Discovery of Functional Mutant Alleles in Cancer. Cancer Discov. 2018;8:174\u201383.","journal-title":"Cancer Discov"},{"key":"2080_CR86","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","volume":"14","author":"SP Suehnholz","year":"2024","unstructured":"Suehnholz SP, Nissan MH, Zhang H, Kundra R, Nandakumar S, Lu C, et al. Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer. Cancer Discov. 2024;14:49\u201365.","journal-title":"Cancer Discov"},{"key":"2080_CR87","unstructured":"Lesluyes T, Tarabichi M, Haase K, Demeulemeester J, Loo P. Robust and platform-independent CNA calling with ASCAT v3. 2023."},{"key":"2080_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189334","volume":"12","author":"V Renault","year":"2017","unstructured":"Renault V, Tost J, Pichon F, Wang-Renault S-F, Letouz\u00e9 E, Imbeaud S, et al. aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations. PLoS ONE. 2017;12: e0189334.","journal-title":"PLoS ONE"},{"key":"2080_CR89","doi-asserted-by":"crossref","unstructured":"Franch-Exp\u00f3sito S, Bassaganyas L, Vila-Casades\u00fas M, Hern\u00e1ndez-Ill\u00e1n E, Esteban-Fabr\u00f3 R, D\u00edaz-Gay M, et al. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.\u00a0Robles-Espinoza CD, Cheah KSE, editors.\u00a0eLife. 2020;9:e50267.","DOI":"10.7554\/eLife.50267"},{"key":"2080_CR90","unstructured":"Heinze G, Ploner M, Jiricka L, Steiner G. coxphf: Cox Regression with Firth\u2019s Penalized Likelihood. 2023. Available from: https:\/\/cran.r-project.org\/web\/packages\/coxphf\/index.html. Cited 2025 May 20."},{"key":"2080_CR91","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS J Integr Biol. 2012;16:284\u20137.","journal-title":"OMICS J Integr Biol"},{"key":"2080_CR92","unstructured":"org.Hs.eg.db. Bioconductor. Available from: http:\/\/bioconductor.org\/packages\/org.Hs.eg.db\/. Cited 2025 May 20."},{"key":"2080_CR93","unstructured":"pairwise_termsim: pairwise_termsim in enrichplot: Visualization of Functional Enrichment Result. Available from: https:\/\/rdrr.io\/bioc\/enrichplot\/man\/pairwise_termsim.html. Cited 2025 May 20."},{"key":"2080_CR94","unstructured":"emapplot function - RDocumentation. Available from: https:\/\/www.rdocumentation.org\/packages\/enrichplot\/versions\/1.13.1.994\/topics\/emapplot. Cited 2025 May 20."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02080-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02080-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02080-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:55:25Z","timestamp":1757210125000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-025-02080-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02080-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.01.25323122","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research ethics board approval was obtained from Sunnybrook Health Sciences Centre, Toronto, Ontario (#2738). This study was facilitated through ICES which is named as a prescribed entity in Sect.\u00a045 of PHIPA (Regulation 329\/04, Sect.\u00a018) which allows access and utilization of administrative data for research purposes with a waived requirement for consent.\u00a0Secure access to these data is governed by policies and procedures that are approved by the Information and\u00a0Privacy Commissioner of Ontario.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}